StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca seloken / Toprol-XL (metoprolol) — US YoY (%) (%)

Form 6-K / 20-F Product Sales Table

QuarterlyAnnual
Latest, Q2 2026
0.0%
Period ended Jun 30, 2026
Change on a year earlier
–
History
14 quarters
Since Q4 2020
Sources
14
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSeloken / Toprol-XL (metoprolol) — US YoY (%) (%)Year on yearSource
Q2 2026Jun 30, 20260.0%–Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 20260.0%–Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 20250.0%–Form 6-K FY2025Q4 Earnings Release ↗
Q1 2024Mar 31, 2024-96.0%-96.0 ptsForm 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 20230.0%0.0 ptsForm 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 20230.0%–Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 20230.0%0.0 ptsForm 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20230.0%–Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 20220.0%–Form 6-K FY2022Q4 Earnings Release ↗
Q2 2022Jun 30, 20220.0%+83.0 ptsForm 6-K FY2022Q2 Earnings Release ↗
Q3 2021Sep 30, 2021-81.0%–Form 6-K FY2021Q3 Earnings Release ↗
Q2 2021Jun 30, 2021-83.0%–Form 6-K FY2021Q2 Earnings Release ↗
Q1 2021Mar 31, 2021-90.0%–Form 6-K FY2021Q1 Earnings Release ↗
Q4 2020Dec 31, 2020-52.0%–Form 6-K FY2020Q4 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Seloken / Toprol-XL (metoprolol) — US YoY (%) (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med_seloken_us_yoy

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.